...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Effects of digoxin, furosemide, enalaprilat and metoprolol on endothelial function in young normotensive subjects.
【24h】

Effects of digoxin, furosemide, enalaprilat and metoprolol on endothelial function in young normotensive subjects.

机译:地高辛,速尿,依那普利拉和美托洛尔对年轻血压正常人群内皮功能的影响。

获取原文
获取原文并翻译 | 示例

摘要

1. Endothelial dysfunction is seen in patients with essential hypertension or congestive heart failure (CHF). The present study aimed to evaluate the direct effect on endothelium- dependent vasodilation (EDV) of different pharmacological drugs commonly used in the treatment of these conditions. 2. Forearm blood flow (FBF) was measured in 37 young healthy normotensive subjects with venous occlusion plethysmography during local intra-arterial infusions of methacholine (MCh; 2-4 microg/min), evaluating EDV, and sodium nitroprusside (SNP; 5-10 microg/min), evaluating endothelium-independent vasodilation (EIDV). The measurements of EDV and EIDV were undertaken under baseline conditions and were repeated after 1 h intra-arterial infusion of digoxin (0.1 mg/h), furosemide (5.0 mg/h), enalaprilat (2,4 mg/h), metoprolol (1.2 mg/h) or saline (controls). 3. Enalaprilat and digoxin improved the FBF response to MCh at 4 microg/min (from 22.7+/-2.3 to 25.5+/-2.1 mL/min per 100 mL tissue (P < 0.01) and from 18.2+/-2.4 to 22.2+/-2.0 mL/min per 100 mL tissue (P < 0.05), respectively). No significant changes where induced by furosemide or metoprolol in response to MCh at 4 microg/min (from 19.4+/-2.0 to 22.9+/-2.8 and from 15.3+/-2.4 to 14.7+/-1.1 mL/min per 100 mL tissue, respectively). No significant changes in basal FBF or EIDV were induced by the different drugs. When the endothelial function index was calculated as the MCh: SNP FBF ratio, a significant improvement was seen only with enalaprilat (1.1+/-0.1 to 1.2+/-0.1; P < 0.01) and furosemide (1.0+/-0.1 to 1.3+/-0.4; P < 0.05). 4. In conlusion, the results of the present study show that enalaprilat and furosemide improve endothelial vasodilatory function, while no major effect was induced by digoxin or metoprolol. Thus, different direct effects on the endothelium in young normotensive subjects were induced by drugs commonly used in the treatment of hypertension or CHF.
机译:1.原发性高血压或充血性心力衰竭(CHF)患者可见内皮功能障碍。本研究旨在评估通常用于治疗这些疾病的不同药理药物对内皮依赖性血管舒张(EDV)的直接作用。 2.在乙酰甲胆碱(MCh; 2-4微克/分钟)局部动脉内输注期间,对37例年轻健康的正常血压受试者进行静脉闭塞体积描记法测量前臂血流量(FBF),评估EDV和硝普钠(SNP; 5- 10微克/分钟),评估非内皮依赖性血管舒张(EIDV)。 EDV和EIDV的测量是在基线条件下进行的,在动脉内输注地高辛(0.1 mg / h),速尿(5.0 mg / h),依那普利拉(2.4 mg / h),美托洛尔( 1.2 mg / h)或生理盐水(对照组)。 3.依那普利拉和地高辛以4 microg / min的速度改善了对MCh的FBF反应(从每100 mL组织22.7 +/- 2.3降至25.5 +/- 2.1 mL / min(P <0.01),从18.2 +/- 2.4降至22.2每100 mL组织+/- 2.0 mL / min(P <0.05)。呋塞米或美托洛尔以4 microg / min对MCh的响应(每100 mL从19.4 +/- 2.0至22.9 +/- 2.8和从15.3 +/- 2.4至14.7 +/- 1.1 mL / min)诱导时无明显变化组织)。不同药物未引起基础FBF或EIDV的显着变化。当将内皮功能指数计算为MCh:SNP FBF比时,只有依那普利拉(1.1 +/- 0.1至1.2 +/- 0.1; P <0.01)和呋塞米(1.0 +/- 0.1至1.3)才能看到显着改善+/- 0.4; P <0.05)。 4.结论是,本研究的结果表明,依那普利拉和速尿改善了内皮血管舒张功能,而地高辛或美托洛尔未引起主要作用。因此,通常用于治疗高血压或CHF的药物对年轻的正常血压受试者的内皮有不同的直接作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号